Answers are grounded in this paper and cite their sources.
Case report demonstrates therapeutic benefits of dual-wavelength lasers and topical sirolimus in pediatric lymphangioma circumscriptum, highlighting a targeted multimodal approach.
Lymphangioma circumscriptum (LC) is a rare lymphatic malformation majorly localized in the skin. We report a case of 12-year-old girl with LC which was simultaneously treated with carbon dioxide laser (10600 nm) and 1540 nm non-ablative fractional laser, followed by topical sirolimus during and after the procedure for a total of seven sessions. Simultaneous combination of 1540 nm non-ablative fractional and CO2 laser as a targeted therapeutic strategy for LC has been limited to one case in the past, but without the use of sirolimus. This report highlights the application and immediate outcomes of this combined use of different lasers along with topical sirolimus, underscoring its potential relevance for future clinical practice and research.
No takes yet. Share an insight, caveat, or question.
Kulkarni et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: